🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
The goal of this clinical trial is to study the addition of Acalabrutinib t...
Status
Recruiting
Location
Saarland University Medical Center
Start Date
2023-06-07
Trial ID
NCT05820841
Treatments Being Tested
This is a phase II trial, with the aim of developing a chemotherapy-free re...
Status
Active Not Recruiting
Location
Department of Hematology X, Odense University Hospital
Start Date
2021-12-15
Trial ID
NCT05214183
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of surovatam...
Status
Recruiting
Location
Research Site
Start Date
2025-01-30
Trial ID
NCT06564038
Phase 3 randomized, double-blind, placebo-controlled, study assessing the e...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-10-08
Trial ID
NCT04529772
Treatments Being Tested
This is a global, multicenter, randomized, open-label, Phase III confirmato...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2024-04-07
Trial ID
NCT06319456
Treatments Being Tested
An observational study to assess the effectiveness, health economic-relevan...
Status
Recruiting
Location
Universitaetsklinikum St. Poelten /ID# 221152
Start Date
2017-12-04
Trial ID
NCT03342144
This study is designed to evaluate the efficacy of acalabrutinib compared w...
Status
Active Not Recruiting
Location
Research Site
Start Date
2017-02-02
Trial ID
NCT02970318
Treatments Being Tested
Study to determine the preliminary safety, tolerability, and pharmacokineti...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2021-03-02
Trial ID
NCT04419389
The purpose of this study is to evaluate the efficacy and safety of acalabr...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-02-25
Trial ID
NCT03836261
Treatments Being Tested